DRUG BRIGHT MINDS BIOSCIENCES INC.

Nasdaq brightmindsbio.com


$ 56.11 $ 3.94 (7.55 %)    

Thursday, 06-Nov-2025 15:59:51 EST
QQQ $ 613.36 $ -9.99 (-1.61 %)
DIA $ 470.23 $ -2.78 (-0.59 %)
SPY $ 671.96 $ -6.30 (-0.93 %)
TLT $ 89.61 $ 0.21 (0.23 %)
GLD $ 367.27 $ -1.11 (-0.3 %)
$ 56.11
$ 52.13
$ 55.01 x 20
$ 57.00 x 7
$ 52.13 - $ 56.82
$ 23.18 - $ 70.23
108,159
na
253.85M
$ 2.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-sugge...

Core News & Articles

https://www.marijuanamoment.net/new-york-lawmakers-hold-hearing-psilocybins-medical-benefits-amid-broader-debate-over-psychedel...

 hc-wainwright--co-reiterates-buy-on-bright-minds-biosciences-maintains-85-price-target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maintai...

Core News & Articles

https://www.marijuanamoment.net/massachusetts-lawmakers-approve-bill-to-create-psychedelic-therapy-pilot-program/

 large-patient-population-is-key-driver-for-bright-minds-growth

BTIG initiates coverage on Bright Minds Biosciences with a Buy rating, citing BMB‑101's potential and key Phase 2 data expe...

 btig-initiates-coverage-on-bright-minds-biosciences-with-buy-rating-announces-price-target-of-72

BTIG analyst Thomas Shrader initiates coverage on Bright Minds Biosciences (NASDAQ:DRUG) with a Buy rating and announces Pri...

Core News & Articles

https://www.marijuanamoment.net/military-to-start-testing-service-members-for-the-psychedelic-psilocin-memo-shows/

Core News & Articles

https://www.marijuanamoment.net/gop-senator-is-confident-psychedelics-access-will-expand-under-trump-saying-many-veterans-speak...

 hc-wainwright--co-reiterates-buy-on-bright-minds-biosciences-maintains-85-price-target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maintai...

Core News & Articles

https://www.marijuanamoment.net/massachusetts-psychiatric-society-endorses-bill-to-decriminalize-psilocybin-possession/

Core News & Articles

https://www.marijuanamoment.net/california-governor-hes-all-in-on-psychedelic-therapy-access-but-worries-about-capitalists-comm...

Core News & Articles

https://www.washingtonpost.com/health/2025/07/16/psychedelics-rfk-jr-kennedy-ibogaine-mdma/41658b06-6246-11f0-bf70-56d8888ebb94...

Core News & Articles

https://www.foxnews.com/health/key-living-longer-could-tied-surprising-substance-study-suggests

 cantor-fitzgerald-assumes-bright-minds-biosciences-at-overweight

Cantor Fitzgerald analyst Pete Stavropoulos assumes Bright Minds Biosciences (NASDAQ:DRUG) with a Overweight rating.

Core News & Articles

https://www.bloomberg.com/news/articles/2025-06-30/colorado-moves-to-allow-hallucinogen-ibogaine-for-medical-use?embedded-check...

Core News & Articles

https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-mari

Core News & Articles

https://www.marijuanamoment.net/rfk-says-trump-administration-could-provide-psychedelic-therapy-to-military-veterans-within-12-...

Core News & Articles

https://www.statnews.com/2025/06/18/fda-approval-psychedelics-rfk-jr-trump-allies-see-opening-mdma-psilocybin-mental-health-tre...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION